Tag Archives: Change in AWP

Good news for plans sponsors who want to reduce their prescription drug costs: generics will continue to be used instead of brands. Bad news: these generics will continue to escalate in cost! The huge jump in many generics during 2014 was not a one-time anomaly.   We expect that generics will continue to rise, and coupled […]

Here we are approaching the one-year anniversary (September 26, 2010) of the effective date of the McKesson AWP settlement, and unfortunately, little has changed.  At WBC (wbcbaltimore.com) we have followed this case from the get-go, through negotiation and settlement. We have helped our clients with their direct participation in the class action settlement, as well as active involvement […]

Plan sponsors are requiring more from their PBMs…. more service, more transparency, more cost reduction. What are the industry trends that will influence the PBM industry’s ability and willingness to deliver?  WBC, along with our subsidiary PharmaSeer, gazes into our crystal ball to predict what you can expect…. Top 10 Trends for 2010/2011 and Beyond: 1. Value-Based Plan Design. […]